Skip to main content
Year archive

Pharming Group N.V. — 2016 filings

All 25 regulatory filings released by Pharming Group N.V. (PHARM) in 2016, sourced directly from the official regulator.

25 Filings
2016 Period
2016 filings (25)
Filing Released Lang
Pharming announces completion of acquisition of all North American commercialisation rights for RUCONEST® from Valeant
Capital/Financing Update
2016-12-08 English
Pharming announces completion of financing for RUCONEST® North American Rights Acquisition
Capital/Financing Update
2016-12-07 English
Pharming Launches Rights Issue to raise €12.1 million as part of RUCONEST® North American Rights Acquisition Financing
Share Issue/Capital Change
2016-11-22 English
Pharming Announces Financing Plans for Closing of RUCONEST® North American Rights Acquisition
Capital/Financing Update
2016-11-21 English
Pharming Announces the Presentation of the Results of the RUCONEST® Phase II Study for Prophylaxis of Hereditary Angioedema Attacks
Regulatory Filings
2016-11-14 English
Pharming announces update on financing
Regulatory Filings
2016-11-14 English
CHMP Adopts Positive Opinion to Include Self-administration for RUCONEST®
Regulatory Filings
2016-11-11 English
Pharming Reports on Financial Results for the First Nine Months of 2016
Interim / Quarterly Report 9M 2016
2016-10-31 English
Pharming Reports on Extraordinary General Meeting of Shareholders
Share Issue/Capital Change
2016-10-06 English
Pharming Reports on Financial Results for the First Eight Months of 2016
Interim / Quarterly Report 9M 2016
2016-10-03 English
Pharming Convene an Extraordinary General Meeting of Shareholders
Capital/Financing Update
2016-08-23 English
Pharming Announces Acquisition of all North American Commercialisation Rights to RUCONEST® From Valeant
M&A Activity
2016-08-09 English
Earnings Release 2016
Earnings Release H1 2016
2016-07-28 English
Pharming Announces Positive Results from Randomized Controlled Trial with RUCONEST® for HAE Prophylaxis
Earnings Release Q3 2016
2016-07-18 English
PHARMING Amends RUCONEST Distribution Agreement with SOBI
Regulatory Filings
2016-07-14 English
Pharming Reports on Annual General Meeting of Shareholders Pharming's Board of Supervisory Directors Announce Paul Sekhri as New Chairman
AGM Information
2016-05-26 English
Pharming Group: Interim Report on Financial Results for Q1 2016
Interim / Quarterly Report Q1 2016
2016-05-18 English
Pharming Group Supports hae day :-) 2016
Environmental & Social Information
2016-05-16 English
Pharming Announces Adoption by the European Commission of the CHMP Recommendation to Change the Terms of the Marketing Authorisation for Ruconest®
Regulatory Filings
2016-04-07 English
Annual Report 2015
Annual Report FY 2015
2016-03-24 English
Pharming Group Report on Preliminary Financial Results 2015
Annual Report FY 2015
2016-03-10 English
Home Member State Declaration Pursuant to the Amended Article 5:25a Paragraph 2 of the Dutch Financial Supervision Act
Regulatory Filings
2016-02-29 Dutch
Pharming Announces Positive CHMP Opinion to Change the Terms of the Marketing Authorisation for Ruconest®
Regulatory Filings
2016-02-26 English
Pharming and Cytobioteck Announce Extension of Distribution Agreement for RUCONEST®
Regulatory Filings
2016-02-09 English
Pharming Announces Completion of Patient Enrolment in Clinical Study of RUCONEST® for Prophylaxis of Hereditary Angioedema
Regulatory Filings
2016-01-06 English